Clinical Trials

egnite, Inc. adds two distinguished physicians Medical Advisory Board

egnite, Inc., a leading digital health company specializing in cardiovascular care, today announced the addition of two distinguished physicians, Vinod H. Thourani, MD and Nicholas Amoroso, MD, to its Medical Advisory Board. Their wealth of expertise in cardiovascular care and dedication to innovation will significantly contribute to egnite’s mission to improve cardiovascular patient care nationwide.

Dr. Thourani is the Bernie Marcus Chairman of the Department of Cardiovascular Surgery for Piedmont Heart Institute and Piedmont Healthcare and the Marcus Heart Valve Center, strengthening egnite’s medical advisory board with his background in cardiovascular surgery and academic research. Over Thourani’s distinguished career, he has held key leadership positions as the past-president of the Southern Thoracic Surgical Association, past-president of the Heart Valve Society, past-president of the International Society of Minimally Invasive Cardiothoracic Surgery, president-elect of the 21st Century Cardiothoracic Surgical Society, past-president of the South Atlantic Cardiovascular Surgery, and the Treasurer of the Society of Thoracic Surgeons. He has authored over 740 peer-reviewed publications in major medical journals. Thourani’s leadership roles in prominent cardiovascular associations and research underscore his invaluable contributions to furthering egnite’s mission and the direction of its flagship solution, the CardioCare platform.

Nicholas Amoroso, MD, is an interventional cardiologist and director of the Medical University of South Carolina’s Adult Cardiac Catheterization Laboratory who brings expertise in structural heart and coronary artery disease to the advisory board. Amoroso is an emerging leader in the field, serving as an investigator for several landmark structural heart clinical trials and as a proctor for novel structural heart interventions. Amoroso’s prominent background in cardiology includes medical training at George Washington University as well as residency and fellowship programs at NYU and Mount Sinai Beth Israel. His involvement in novel clinical trials and contributions to leading cardiology research brings a wealth of experience to egnite’s medical advisory board.

“We are honored to welcome Vinod and Nick to egnite’s Medical Advisory Board,” said Joel Portice, president and CEO of egnite. “Their collective expertise will play a pivotal role in shaping the future of digital health for cardiovascular patients. I look forward to Vinod and Nick’s partnership as we continue to develop innovative solutions in the cardiovascular community.”

The appointment of Thourani and Amoroso to its Medical Advisory Board underscores egnite’s commitment to excellence and advancement in developing solutions to address the evolving needs of cardiovascular patients and providers.

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

Related posts

HealthVerity announced general availability of HealthVerity FLOW 1.1

PR Newswire

ClinChoice acquires CSI, expands Global Footprint into Southeast Asia

PR Newswire

Spectrum Science acquires Continuum Clinical

PR Newswire